Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 21, 2024

BUY
$24.4 - $41.3 $5,563 - $9,416
228 New
228 $8,000
Q3 2022

Oct 21, 2022

SELL
$28.48 - $52.59 $2,677 - $4,943
-94 Reduced 29.19%
228 $6,000
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $333,917 - $744,739
-9,037 Reduced 96.56%
322 $15,000
Q1 2022

Apr 25, 2022

SELL
$55.7 - $145.79 $541,515 - $1.42 Million
-9,722 Reduced 50.95%
9,359 $712,000
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $2.58 Million - $3.48 Million
19,081 New
19,081 $2.84 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.